publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
background
acut
otiti
media
aom
common
complic
viral
upper
respiratori
infect
uri
children
virusinduc
host
inflammatori
respons
nasopharynx
play
key
role
pathogenesi
aom
suppress
inflammatori
process
might
prevent
develop
aom
complic
object
sought
assess
effect
intranas
administ
fluticason
propion
prevent
aom
viral
respiratori
infect
method
total
children
mean
age
year
rang
year
normal
middl
ear
statu
uri
hour
durat
less
randomli
alloc
receiv
either
fluticason
twice
daili
placebo
day
specif
viral
caus
infect
determin
nasopharyng
aspir
obtain
first
visit
children
reexamin
end
medic
period
result
fluticason
group
aom
develop
children
compar
children
receiv
placebo
p
viral
caus
respiratori
infect
determin
children
nasopharyng
aspir
obtain
children
rhinoviru
infect
aom
develop
significantli
often
fluticason
group
placebo
group
p
conclus
intranas
administ
fluticason
prevent
develop
aom
uri
may
increas
incid
aom
rhinoviru
infect
j
allergi
clin
immunol
acut
otiti
media
aom
frequent
complic
viral
upper
respiratori
infect
uri
children
effect
method
prevent
develop
aom
would
utmost
import
high
incid
rate
substanti
cost
potenti
longterm
development
sequela
diseas
unfortun
prevent
method
current
avail
increas
antimicrobi
resist
bacteria
may
complic
treatment
aom
emphas
need
search
new
prevent
method
basi
knowledg
pathogenet
mechan
aom
respiratori
virus
initi
cascad
event
final
lead
develop
aom
virus
known
induc
releas
inflammatori
mediat
eg
histamin
leukotrien
kinin
interleukin
target
cell
nasopharynx
intranas
challeng
mani
mediat
shown
provok
dysfunct
eustachian
tube
consid
import
factor
develop
aom
eustachian
tube
dysfunct
caus
neg
pressur
middl
ear
may
eventu
lead
product
middl
ear
effus
median
time
onset
uri
develop
aom
day
provid
window
opportun
intervent
prevent
aom
host
inflammatori
respons
uri
play
central
role
pathogenesi
aom
could
hypothes
use
potent
antiinflammatori
agent
corticosteroid
might
suppress
inflammatori
process
prevent
develop
aom
complic
experiment
studi
rhinoviru
infect
adult
glucocorticoid
shown
reduc
inflamm
nasopharynx
first
day
infect
conduct
random
doubleblind
placebocontrol
studi
assess
whether
fluticason
propion
fp
administ
intranas
earli
cours
uri
would
prevent
develop
aom
children
furthermor
discov
asthma
rhiniti
respiratori
diseas
intranas
fluticason
propion
prevent
acut
otiti
media
viral
upper
respiratori
infect
children
potenti
differ
effect
fp
differ
viral
infect
use
extens
method
determin
specif
viral
caus
uri
studi
particip
recruit
inform
famili
daycar
center
famili
daycar
health
center
wellbabi
clinic
local
media
turku
area
februari
april
children
qualifi
enrol
younger
year
sign
symptom
uri
start
within
preced
hour
exclus
criteria
follow
middl
ear
effus
either
ear
infect
requir
antimicrobi
therapi
use
antimicrobi
agent
steroid
preced
week
previou
adenoidectomi
placement
tympanostomi
tube
known
immunodefici
syndrom
cleft
palat
use
investig
drug
preced
week
children
initi
examin
studi
clinic
exclud
particip
aom
otiti
media
effus
random
doubleblind
placebocontrol
studi
parent
particip
gave
written
inform
consent
studi
protocol
approv
ethic
committe
turku
univers
hospit
children
examin
studi
clinic
within
hour
onset
uri
middl
ear
statu
care
examin
pneumat
otoscopi
addit
tympanometri
whenev
child
cooper
nasopharyng
aspir
specimen
obtain
use
dispos
mucu
extractor
uno
maersk
medic
elig
children
randomli
alloc
receiv
either
intranas
aqueou
fp
per
nostril
twice
daili
total
daili
dose
ident
placebo
day
drug
suppli
glaxowellcom
uk
first
dose
given
studi
clinic
parent
care
taught
administ
medic
nostril
child
parent
provid
diari
card
daili
record
child
symptom
rhiniti
cough
fever
earach
medic
given
possibl
advers
event
children
reexamin
end
medic
period
addit
meantim
whenev
parent
suspect
aom
studi
physician
inquir
complianc
medic
occurr
advers
event
visit
end
studi
period
diari
card
collect
visit
free
charg
famili
compens
particip
studi
nasopharyng
aspir
process
freshli
antigen
detect
timeresolv
fluoroimmunoassay
describ
earlier
virus
includ
antigen
detect
panel
respiratori
syncyti
viru
parainfluenza
viru
type
influenza
b
virus
adenoviru
immedi
collect
nasopharyng
aspir
steril
cotton
swab
dip
aspir
insert
vial
contain
viral
transport
medium
tryptos
phosphat
broth
bsa
antibiot
pb
store
later
rtpcr
analysi
posit
control
sever
neg
control
includ
pcr
analysi
contamin
specimen
prevent
strict
precaut
includ
use
separ
room
step
rtpcr
assay
nucleic
acid
sequenc
rhinovirus
enterovirus
detect
rtpcr
assay
subsequ
timeresolv
fluorometr
microwel
hybrid
assay
gel
electrophoresi
ethidium
bromid
stain
cutoff
valu
hybridizationposit
specimen
time
mean
valu
water
templat
control
hybridizationposit
specimen
identifi
rhinoviru
enteroviru
least
differ
fluoresc
valu
rhinovirusand
enterovirusspecif
probe
second
rtpcr
analysi
done
aliquot
rna
specimen
yield
visibl
band
correspond
expect
amplicon
size
agaros
gel
gave
neg
dualposit
hybrid
result
use
anoth
pcr
primer
pair
rhinovirus
enterovirus
could
discrimin
amplicon
size
picornavirusposit
amplicon
first
pcr
could
resolv
rhinovirus
enterovirus
hybrid
assay
second
rtpcr
analysi
regard
unclassifi
picornavirus
addit
specimen
neg
accord
method
describ
test
inhous
rtpcr
assay
human
coronaviru
strain
wari
unpublish
data
primer
probe
modifi
primer
nucleotid
sequenc
either
describ
earlier
avail
genebank
synthes
eurogentec
sera
belgium
pcr
product
detect
use
agaros
gel
electrophoresi
ethidium
bromid
stain
band
correspond
amplicon
size
identifi
gel
result
confirm
southern
hybrid
aom
defin
presenc
middl
ear
effus
basi
appear
mobil
tympan
membran
togeth
one
sign
symptom
acut
infect
rhiniti
cough
fever
earach
irrit
experienc
otoscopist
ar
perform
otoscop
examin
studi
diagnosi
uri
base
newonset
rhiniti
alon
rhiniti
togeth
cough
fever
cough
fever
without
sign
lower
respiratori
infect
durat
uri
symptom
rhiniti
cough
fever
record
whole
day
part
defin
day
prespecifi
primari
outcom
measur
number
attack
aom
estim
aom
would
develop
children
receiv
placebo
detect
reduct
number
attack
aom
signific
level
power
minimum
requir
number
children
group
pearson
test
use
analyz
occurr
aom
treatment
group
among
rhinovirusposit
children
associ
primari
outcom
variabl
aom
predict
variabl
risk
factor
aom
use
fp
studi
use
multivari
logist
regress
analysi
probabl
p
valu
less
consid
statist
signific
p
valu
twosid
total
children
random
one
child
discontinu
studi
medic
anoth
use
improperli
children
accept
complet
studi
receiv
fp
receiv
placebo
demograph
characterist
group
compar
except
parent
smoke
frequent
fp
group
tabl
complianc
medic
good
singl
dose
miss
children
fp
group
children
placebo
group
advers
event
record
bloodting
nasal
mucu
fp
placebo
group
herp
simplex
vesicl
one
placebo
group
hospit
caus
pneumonia
one
fp
group
children
fp
group
aom
develop
treatment
children
placebo
group
aom
diagnos
children
differ
statist
signific
p
median
day
diagnos
aom
day
studi
ie
day
preplan
control
visit
sixteen
case
aom
diagnos
day
case
day
studi
median
durat
rhiniti
cough
fever
commenc
studi
medic
day
respect
group
specif
viral
caus
uri
determin
children
nasopharyng
aspir
specimen
obtain
tabl
ii
rhinoviru
frequent
found
caus
agent
occur
total
children
enterovirus
detect
children
among
rhinovirusand
enterovirusposit
children
demograph
characterist
compar
treatment
group
well
children
data
shown
children
rhinoviru
singl
caus
agent
aom
develop
fp
recipi
compar
children
receiv
placebo
p
tabl
iii
even
adjust
known
risk
factor
aom
age
sex
breastfeed
parent
smoke
use
pacifi
daycar
outsid
home
use
fp
significantli
associ
increas
incid
aom
odd
ratio
confid
interv
p
signific
differ
observ
occurr
aom
fp
placebo
group
children
caus
uri
tabl
iii
result
studi
demonstr
intranas
administ
fp
start
earli
cours
viral
uri
prevent
develop
aom
young
children
find
good
accord
previou
studi
efficaci
steroid
treatment
prevent
uri
adult
experiment
studi
rhinoviru
infect
gustafson
et
al
show
although
oral
prednison
therapi
decreas
local
kinin
concentr
nasopharynx
allevi
clinic
symptom
volunt
anoth
experiment
studi
combin
intranas
beclomethason
oral
prednison
modest
shortliv
effect
clinic
symptom
patient
infect
rhinovirus
recent
puhakka
et
al
studi
efficaci
intranas
administ
fp
treatment
natur
common
cold
otherwis
healthi
young
adult
report
treatment
neither
decreas
incid
sinus
diminish
clinic
symptom
patient
result
studi
includ
present
one
clearli
indic
steroid
treatment
alon
may
effect
reduc
sever
durat
symptom
uri
prevent
develop
common
complic
aom
sinus
find
treatment
fp
significantli
increas
incid
aom
rhinoviru
infect
entir
unexpect
observ
may
substanti
clinic
implic
rhinovirus
common
caus
agent
uri
steroid
wide
use
treatment
variou
condit
children
adult
explan
readili
avail
increas
risk
aom
caus
fp
treatment
rhinoviru
infect
system
effect
fp
unlik
system
bioavail
drug
intranas
administr
low
adult
use
steroid
rhinoviru
infect
shown
increas
viral
titer
nasopharynx
result
prolong
shed
rhinovirus
way
steroid
might
inten
sifi
rather
suppress
inflammatori
reaction
nasopharynx
could
lead
sever
dysfunct
eustachian
tube
theori
may
howev
suffici
explain
present
observ
steroid
report
increas
viral
shed
also
infect
caus
rhinoviru
furthermor
recent
vitro
studi
suggest
steroid
direct
effect
rhinoviru
replic
cultur
respiratori
epitheli
cell
found
effect
fp
incid
aom
children
uri
caus
enterovirus
virus
howev
exclud
possibl
intranas
fp
might
even
prevent
aom
viral
infect
incid
mani
viral
infect
low
meaning
analysi
taken
togeth
find
suggest
effect
fp
perhap
steroid
gener
may
vari
significantli
differ
viral
infect
use
extens
method
detect
virus
nasopharyng
aspir
enabl
us
determin
specif
viral
caus
uri
children
despit
high
recoveri
rate
virus
rel
distribut
differ
type
virus
studi
generaliz
unselect
group
children
exclud
almost
one
third
children
brought
studi
clinic
alreadi
aom
also
probabl
parent
sickest
children
want
particip
clinic
trial
reason
might
least
partli
explain
low
rate
respiratori
syncyti
viru
influenza
virus
studi
children
spite
limit
result
suggest
enterovirus
promin
role
caus
uri
children
although
enterovirus
identifi
caus
uri
children
previous
descript
enteroviru
infect
mostli
concentr
larg
outbreak
sever
ill
patient
uri
infrequ
includ
list
manifest
enteroviru
infect
conclud
intranas
administ
fp
prevent
develop
aom
uri
children
may
even
increas
risk
aom
rhinoviru
infect
find
suggest
effect
steroid
may
vari
significantli
differ
respiratori
viral
infect
widespread
use
steroid
high
preval
rhinoviru
infect
commun
studi
area
need
thank
kirsimaija
suomela
rn
excel
assist
conduct
studi
taina
md
good
collabor
studi
drug
kindli
suppli
glaxowellcom
uk
